Eupraxia Pharmaceuticals (NASDAQ:EPRX) Stock Price Down 1% – Should You Sell?

Shares of Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) traded down 1% on Tuesday . The stock traded as low as $3.06 and last traded at $3.06. 314 shares changed hands during trading, a decline of 98% from the average session volume of 16,111 shares. The stock had previously closed at $3.09.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. RODMAN&RENSHAW raised Eupraxia Pharmaceuticals to a “strong-buy” rating in a report on Thursday, November 14th. Rodman & Renshaw assumed coverage on shares of Eupraxia Pharmaceuticals in a research note on Thursday, November 14th. They issued a “buy” rating and a $9.00 price objective on the stock.

Eupraxia Pharmaceuticals Trading Down 1.0 %

The company has a market cap of $83.48 million and a price-to-earnings ratio of -4.25. The business has a 50-day moving average price of $3.04 and a 200 day moving average price of $2.76.

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company’s lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee.